DIRC3 and hereditary renal cell carcinoma: DIRC3, first identified as a fusion transcript in familial renal carcinoma as early as 2003, was identified to affect thyroid-stimulating hormone levels and promote TC development through decreasing thyroid epithelium differentiation [18, 19].